A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
LIFE SCIENCE REIT PLC ORD GBP0. operates in the REIT - Industrial industry, Real Estate sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 26M | 26M | 25M | 19M |
| Net Income | -18M | -18M | -27M | -34M |
| EPS | $-0.05 | $-0.05 | $-0.08 | $-0.10 |
| Free Cash Flow | 17M | 17M | 9.5M | -1.3M |
| ROIC | -2.4% | -1.5% | -3.0% | -6.2% |
| Gross Margin | 71.0% | 71.0% | 69.3% | 69.6% |
| Debt/Equity | 0.00 | 0.48 | 0.40 | 0.24 |
| Dividends/Share | $0.03 | $0.03 | $0.05 | $0.01 |
| Operating Income | -10.0M | -10.0M | -18M | -33M |
| Operating Margin | -38.4% | -38.4% | -73.2% | -171.5% |
| ROE | -5.3% | -5.2% | -7.2% | -8.6% |
| Shares Outstanding | 349M | 349M | 350M | 350M |
| Metric | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 19M | 25M | 26M | 26M |
| Gross Margin | 69.6% | 69.3% | 71.0% | 71.0% |
| R&D | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A |
| EBIT | -33M | -18M | -10.0M | -10.0M |
| Op. Margin | -171.5% | -73.2% | -38.4% | -38.4% |
| Net Income | -34M | -27M | -18M | -18M |
| Net Margin | -175.8% | -108.8% | -68.8% | -68.8% |
| Non-Recurring | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||
| ROIC | -6.2% | -3.0% | -1.5% | -2.4% |
| ROE | -8.6% | -7.2% | -5.2% | -5.3% |
| ROA | -6.2% | -5.1% | -3.5% | -3.5% |
| Cash Flow | ||||
| Op. Cash Flow | -1.3M | 9.5M | 17M | 17M |
| Free Cash Flow | -1.3M | 9.5M | 17M | 17M |
| Owner Earnings | -1.3M | 9.5M | 17M | 17M |
| CapEx | 0 | 0 | 0 | 0 |
| Maint. CapEx | 0 | 0 | 0 | 0 |
| Growth CapEx | N/A | N/A | N/A | 0 |
| D&A | 0 | 0 | 0 | 0 |
| CapEx/OCF | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||
| Dividends Paid | 4.3M | 17M | 9.0M | 9.0M |
| Dividend Yield | 1.1% | 6.0% | 5.0% | 0.1% |
| Share Buybacks | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A |
| Debt Repayment | 32M | 181M | 0 | 0 |
| Balance Sheet | ||||
| Net Debt | 40M | 123M | 154M | -7.1M |
| Cash & Equiv. | 56M | 18M | 7.1M | 7.1M |
| Long-Term Debt | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.24 | 0.40 | 0.48 | 0.00 |
| Interest Coverage | -7.1 | -1.3 | -0.7 | -0.7 |
| Equity | 394M | 354M | 336M | 336M |
| Total Assets | 552M | 513M | 513M | 513M |
| Total Liabilities | 158M | 158M | 177M | 177M |
| Intangibles | N/A | N/A | N/A | N/A |
| Retained Earnings | -24M | -52M | -71M | -71M |
| Working Capital | 4.0M | 8.2M | N/A | N/A |
| Current Assets | 66M | 26M | N/A | N/A |
| Current Liabilities | 62M | 18M | 16M | 16M |
| Per Share Data | ||||
| EPS | -0.10 | -0.08 | -0.05 | -0.05 |
| Owner EPS | -0.00 | 0.03 | 0.05 | 0.05 |
| Book Value | 1.13 | 1.01 | 0.96 | 0.96 |
| Cash Flow/Share | -0.00 | 0.03 | 0.05 | -0.05 |
| Dividends/Share | 0.01 | 0.05 | 0.03 | 0.03 |
| Shares Out. | 349.5M | 350.1M | 349.4M | 349.4M |
| Valuation | ||||
| P/E Ratio | -9.2 | -10.4 | -9.6 | -828.6 |
| P/FCF | N/A | 29.7 | 10.3 | 896.3 |
| EV/EBIT | N/A | N/A | N/A | N/A |
| Price/Book | 0.8 | 0.8 | 0.5 | 44.1 |
| Price/Sales | 16.1 | 11.3 | 6.6 | 570.3 |
| FCF Yield | -0.4% | 3.4% | 9.7% | 0.1% |
| Market Cap | 312M | 282M | 171M | 14.8B |
| Avg. Price | 1.15 | 0.84 | 0.51 | 42.40 |
| Year-End Price | 0.89 | 0.81 | 0.49 | 42.40 |
LIFE SCIENCE REIT PLC ORD GBP0. passes 3 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 896.4x vs a median of 20.0x. The company's 5-year average gross margin is 70.0%. At current prices, the estimated annualized return to fair value is +73.7%.
LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L) has a 5-year average return on invested capital (ROIC) of -3.6%. This is below average and may indicate limited pricing power.
LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L) has a market capitalization of $14.8B. It is classified as a large-cap stock.
Yes, LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L) pays a dividend with a trailing twelve-month yield of 0.06%.
LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L) operates in the REIT - Industrial industry, within the Real Estate sector.
LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L) reported annual revenue of $26 million in its most recent fiscal year, based on SEC EDGAR filings.
LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L) has a net profit margin of -68.8%. The company is currently unprofitable.
LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L) generated $17 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L) has a debt-to-equity ratio of 0.48. This indicates a conservatively financed balance sheet.
LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L) reported earnings per share (EPS) of $-0.05 in its most recent fiscal year.
LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L) has a return on equity (ROE) of -5.2%. A negative ROE may indicate losses or negative equity.
LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L) has a 5-year average gross margin of 70.0%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 3 years of financial data for LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
LIFE SCIENCE REIT PLC ORD GBP0. (LABS-L) has a book value per share of $0.96, based on its most recent annual SEC filing.
No recent press releases.